Haemopoiesis Research Laboratory Full Name: Maria Ximeri Phone: + 30 2810 394629 &  2810 392428 FAX: + 30 2810 394632, 2810 392344 E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

EDUCATION

2015: Specialization in Haematology, Department of Haematology, Heraklion University Hospital, Crete, Greece

2005: Degree in Medicine, Health Sciences, University of Crete, Greece

PROFESSIONAL EXPERIENCE

2011 – 2015: Residency in Haematology at the Haematology Department of the University Hospital of Heraklion, Crete, Greece.

2008 – 2011: Residency in Internal Medicine at the Int. Medicine Department of the University Hospital of Heraklion, Crete, Greece.

2006 – present: Clinical Research Fellow at the Haematology Department of the University Hospital of Heraklion, Crete, Greece.

CURRENT AREA OF PROFESSIONAL INTEREST

Haemopoietic Stem Cells and effect of the BM microenvironment in BM failure syndromes

Autologous Stem Cell Transplantation

Cord Blood Banking

Cytometric analysis of cell subsets in haematological diseases

HONORS

2003-2004   I.K.Y (National Institute of Scholarships) award for the academic year of

                    2003-2004 at Heraklion’s Medical School

2008            Best announcement award during 19^th Hellenic Haematology Congress

2016            Scholarship from the Hellenic Society of Haematology for two years

                    (2016- 2018)

SELECTED PUBLICATIONS

• Kouvidi E, Stratigi A, Batsali A, Mavroudi I, Mastrodemou S, Ximeri M, Papadaki HA, Pontikoglou CG. Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion.   Leuk Res. 2016 Apr;43:24-32.
• Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou F, Moschogiannis M, Ximeri M, Tsirkinidis P, Yiakoumis X, Papadaki HA, Vassilakopoulos TP.. Validation of the simplified prognostic score for splenic marginal zone lymphoma of the Splenic Marginal Zone Lymphoma Working Group Leuk Lymphoma. 2014 Nov;55(11):2640-2
• Spanoudakis M, Koutala H, Ximeri M, Pyrovolaki K, Stamatopoulos K, Papadaki HA. . T-cell receptor Vβ repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions Clin Immunol. 2010 Dec;137(3):384-95
• Ximeri M, Galanopoulos A, Klaus M, Parcharidou A, Giannikou K, Psyllaki M, Symeonidis A, Pappa V, Kartasis Z, Liapi D, Hatzimichael E, Kokoris S, Korkolopoulou P, Sambani C, Pontikoglou C, Papadaki HA; Hellenic MDS Study Group.Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion Haematologica. 2010 Mar;95(3):406-14
• Eliopoulos DG, Mavroudi I, Pontikoglou C, Ximeri M, Stavroulaki E, Pyrovolaki K, Velegraki M, Spanoudakis M, Goulielmos G, Papadaki HAThe -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.. Eur J Haematol. 2009 Dec 1;83(6):535-40
• Pyrovolaki K, Mavroudi I, Papadantonakis N, Velegraki M, Ximeri M, Kalpadakis C, Gvazava G, Klaus M, Eliopoulos GD, Papadaki HA.Transforming growth factor-beta1 affects interleukin-10 production in the bone marrow of patients with chronic idiopathic neutropenia. Eur J Haematol. 2007 Dec;79(6):531-8
• Koumaki V, Damianaki A, Ximeri M, Pontikoglou C, Axioti F, Spanoudakis M, Eliopoulos GD, Papadaki HA.. Pro-inflammatory bone marrow milieu in patients with chronic idiopathic neutropenia is associated with impaired local production of interleukin-10. Br J Haematol. 2006 Nov;135(4):570-3